Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 15 studies | 45% ± 19% | |
glutamatergic neuron | 12 studies | 42% ± 23% | |
plasmacytoid dendritic cell | 12 studies | 25% ± 7% | |
oligodendrocyte precursor cell | 11 studies | 34% ± 9% | |
GABAergic neuron | 9 studies | 38% ± 20% | |
interneuron | 6 studies | 46% ± 16% | |
granule cell | 4 studies | 51% ± 17% | |
endothelial cell | 3 studies | 50% ± 19% | |
GABAergic interneuron | 3 studies | 39% ± 28% | |
neuron | 3 studies | 42% ± 20% | |
cardiac muscle cell | 3 studies | 19% ± 5% | |
GABAergic amacrine cell | 3 studies | 24% ± 3% | |
Mueller cell | 3 studies | 37% ± 7% | |
glycinergic amacrine cell | 3 studies | 18% ± 2% | |
endothelial cell of lymphatic vessel | 3 studies | 18% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 11 studies | 36% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 95% | 1836.36 | 2520 / 2642 | 97% | 45.27 | 684 / 705 |
thymus | 91% | 637.01 | 596 / 653 | 60% | 3.60 | 364 / 605 |
skin | 83% | 840.08 | 1494 / 1809 | 21% | 1.51 | 99 / 472 |
muscle | 90% | 509.54 | 724 / 803 | 0% | 0 | 0 / 0 |
intestine | 52% | 402.12 | 506 / 966 | 32% | 2.32 | 169 / 527 |
breast | 56% | 359.16 | 255 / 459 | 24% | 1.69 | 266 / 1118 |
uterus | 56% | 332.17 | 96 / 170 | 18% | 2.33 | 83 / 459 |
adrenal gland | 38% | 119.67 | 97 / 258 | 28% | 2.78 | 64 / 230 |
peripheral blood | 65% | 571.37 | 603 / 929 | 0% | 0 | 0 / 0 |
stomach | 23% | 127.17 | 81 / 359 | 40% | 2.80 | 114 / 286 |
bladder | 43% | 316.19 | 9 / 21 | 16% | 1.24 | 80 / 504 |
prostate | 49% | 253.36 | 119 / 245 | 10% | 0.37 | 49 / 502 |
kidney | 26% | 70.62 | 23 / 89 | 30% | 1.86 | 266 / 901 |
spleen | 50% | 129.75 | 120 / 241 | 0% | 0 | 0 / 0 |
esophagus | 17% | 108.40 | 244 / 1445 | 33% | 2.40 | 60 / 183 |
ovary | 12% | 60.27 | 21 / 180 | 36% | 1.76 | 154 / 430 |
liver | 41% | 146.79 | 92 / 226 | 3% | 0.09 | 11 / 406 |
blood vessel | 39% | 173.22 | 522 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 34% | 7.34 | 10 / 29 |
lung | 2% | 4.38 | 12 / 578 | 30% | 2.65 | 351 / 1155 |
tonsil | 0% | 0 | 0 / 0 | 29% | 2.44 | 13 / 45 |
eye | 0% | 0 | 0 / 0 | 20% | 1.15 | 16 / 80 |
adipose | 17% | 46.40 | 204 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 11% | 0.49 | 20 / 178 |
heart | 3% | 7.66 | 29 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030010 | Biological process | establishment of cell polarity |
GO_0001525 | Biological process | angiogenesis |
GO_0031589 | Biological process | cell-substrate adhesion |
GO_0046328 | Biological process | regulation of JNK cascade |
GO_0048013 | Biological process | ephrin receptor signaling pathway |
GO_0001771 | Biological process | immunological synapse formation |
GO_0050804 | Biological process | modulation of chemical synaptic transmission |
GO_0070372 | Biological process | regulation of ERK1 and ERK2 cascade |
GO_1902723 | Biological process | negative regulation of skeletal muscle satellite cell proliferation |
GO_0048593 | Biological process | camera-type eye morphogenesis |
GO_0061351 | Biological process | neural precursor cell proliferation |
GO_0021631 | Biological process | optic nerve morphogenesis |
GO_0021934 | Biological process | hindbrain tangential cell migration |
GO_0021952 | Biological process | central nervous system projection neuron axonogenesis |
GO_0022008 | Biological process | neurogenesis |
GO_0060996 | Biological process | dendritic spine development |
GO_0050965 | Biological process | detection of temperature stimulus involved in sensory perception of pain |
GO_0014719 | Biological process | skeletal muscle satellite cell activation |
GO_1902725 | Biological process | negative regulation of satellite cell differentiation |
GO_0006468 | Biological process | protein phosphorylation |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0031290 | Biological process | retinal ganglion cell axon guidance |
GO_0051965 | Biological process | positive regulation of synapse assembly |
GO_0060326 | Biological process | cell chemotaxis |
GO_0007411 | Biological process | axon guidance |
GO_0060997 | Biological process | dendritic spine morphogenesis |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0031901 | Cellular component | early endosome membrane |
GO_0032433 | Cellular component | filopodium tip |
GO_0070062 | Cellular component | extracellular exosome |
GO_0030425 | Cellular component | dendrite |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0030424 | Cellular component | axon |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0008046 | Molecular function | axon guidance receptor activity |
GO_0005005 | Molecular function | transmembrane-ephrin receptor activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | EPHB1 |
Protein name | Ephrin type-B receptor 1 (EC 2.7.10.1) (ELK) (EPH tyrosine kinase 2) (EPH-like kinase 6) (EK6) (hEK6) (Neuronally-expressed EPH-related tyrosine kinase) (NET) (Tyrosine-protein kinase receptor EPH-2) EPH receptor B1 receptor protein-tyrosine kinase (EC 2.7.10.1) |
Synonyms | ELK HEK6 EPHT2 NET |
Description | FUNCTION: Receptor tyrosine kinase which binds promiscuously transmembrane ephrin-B family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Cognate/functional ephrin ligands for this receptor include EFNB1, EFNB2 and EFNB3. During nervous system development, regulates retinal axon guidance redirecting ipsilaterally ventrotemporal retinal ganglion cells axons at the optic chiasm midline. This probably requires repulsive interaction with EFNB2. In the adult nervous system together with EFNB3, regulates chemotaxis, proliferation and polarity of the hippocampus neural progenitors. In addition to its role in axon guidance also plays an important redundant role with other ephrin-B receptors in development and maturation of dendritic spines and synapse formation. May also regulate angiogenesis. More generally, may play a role in targeted cell migration and adhesion. Upon activation by EFNB1 and probably other ephrin-B ligands activates the MAPK/ERK and the JNK signaling cascades to regulate cell migration and adhesion respectively. Involved in the maintenance of the pool of satellite cells (muscle stem cells) by promoting their self-renewal and reducing their activation and differentiation (By similarity). . |
Accessions | F8WDG5 ENST00000398015.8 [P54762-1] ENST00000474732.1 ENST00000497173.5 C9J6S4 ENST00000647596.1 C9K090 ENST00000482618.5 C9J466 A0A3B3IRY8 P54762 ENST00000473867.5 ENST00000493838.1 [P54762-5] |